The regulations you actually have to pass — in plain English.
Clause-by-clause readiness guides across pharma, medical devices, food and cosmetics. Each one ends with the evidence inspectors ask for and a 60–90 day path to get there.
21 CFR Part 11 Readiness Guide for Regulated Manufacturers
Plain-English guide to FDA 21 CFR Part 11 — electronic records, electronic signatures, audit trails, and a practical path to a Part 11-compliant eQMS without theatre.
Supplements & Nutraceuticals
Dietary supplement cGMP, claims, formats and ingredient identity.
21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
21 CFR 111 is FDA's cGMP for dietary supplements. Subpart E (component identity testing) and Subpart F (production and process control records) are the FDA-483 hot zones — this guide maps both into a defensible readiness workflow.
AAFCO Nutrient Profile & Pet Food Labeling
Operating manual for AAFCO nutrient profiles, the complete-and-balanced statement, feeding trials and pet-food labelling — including the AAFCO PFLR modernised label transition.
Africa Supplement Regulation: SAHPRA, NAFDAC, Kenya PPB & AU Harmonisation
African supplement market readiness — South Africa SAHPRA complementary medicines, Nigeria NAFDAC dietary supplements, Kenya PPB, Ghana FDA, Egypt EDA and the African Medicines Agency (AMA) harmonisation roadmap.
Allergen Control in Supplement Manufacturing: Validation, Cleaning, Labelling
Allergen control for dietary supplements — FALCPA/FASTER big-9 allergens, validated cleaning, shared-line controls, label declarations and the precautionary advisory.
ASEAN Supplement Regulation: Indonesia BPOM, Thai FDA, Vietnam MoH, Philippine FDA
ASEAN supplement readiness — Indonesia BPOM Suplemen Kesehatan, Thailand FDA dietary supplements, Vietnam MoH functional foods, Philippine FDA food supplements, Malaysia NPRA, halal certification and ASEAN harmonisation roadmap.
ASEAN Supplements Readiness: Singapore HSA and the Regional Hub
ASEAN supplements — Singapore HSA health supplement framework, ASEAN harmonisation and how a Singapore listing opens Malaysia NPRA, Thailand FDA and Indonesia BPOM.
Australia TGA Listed Medicines: AUST L, Permitted Ingredients & Claims
Australia supplement market readiness — TGA Listed Medicines AUST L pathway, Permitted Ingredients Determination, permitted indications list, Listed Assessed (AUST L(A)), GMP licence and lifecycle controls.
Botanical Identity Testing: FTIR, HPTLC and DNA Barcoding for Supplement Ingredients
Botanical identity testing for supplements — orthogonal methods (FTIR, HPTLC, DNA barcoding, macro/microscopy) above the 21 CFR 111 single-test minimum.
Botanical Sustainability for Supplements: FairWild, UEBT, CITES & Wild-Harvest Risk
Botanical sustainability — FairWild Standard, UEBT (Union for Ethical BioTrade), CITES-listed botanicals, wild-harvest vs cultivated sourcing, biodiversity risk and the supply chain due diligence dossier.
Brazil ANVISA Supplements Readiness: RDC 243/2018 and the Notification Regime
Brazil supplements — ANVISA RDC 243/2018 food supplement category, ingredient and claim positive lists, notification, and Mercosul GMP alignment.
CBD & Hemp Supplements: Federal vs State, 0.3% THC, FDA Position & Banking
CBD and hemp supplement readiness — 2018 Farm Bill 0.3% delta-9 THC threshold, FDA position on CBD in supplements, state-by-state divergence, banking/processing constraints, testing controls and adverse event monitoring.
Children's Supplements: Dosing, Choking Hazards, Iron Overdose & Label Controls
Children's supplement readiness — age-band dosing, iron overdose warning, choking hazard controls for gummies/chewables, sugar and sweetener limits, allergen handling, child-resistant closures and pharmacovigilance.
Contract Manufacturing QMS for Supplements: Brand Owner Quality Agreement
Contract manufacturing QMS for supplements — brand-owner vs CMO responsibilities, the FDA Quality Agreement Guidance, 21 CFR 111 own-label distributor rule, NSF 455-1.
Dietary Supplement cGMP Readiness: The V5 Hub
Hub guide for dietary supplement manufacturers and brand-owners — 21 CFR 111 cGMP, NDI notification, structure/function claims, identity testing (Subpart E), serious AER reporting and NSF 173 / USP 2750 third-party certification.
Digital Labels for Supplements: SmartLabel, EU QR Code & Off-Pack Labelling
Digital labels for supplements — GS1 SmartLabel (US), EU off-pack labelling and QR-coded ingredient and origin disclosure, regulatory framework, GDPR considerations, and the unified label data backbone.
Encapsulation, Coating & Delayed-Release Supplement Technology
Supplement encapsulation and coating technology — enteric coating, delayed-release, microencapsulation, liposomal delivery, sustained-release matrices and the dissolution and stability validation required for the technology claim.
EU Food Supplements Directive 2002/46/EC Readiness
Directive 2002/46/EC sets the EU baseline for food supplements — permitted vitamin/mineral sources and the national notification regimes (BVL, DGCCRF, Min. Salute).
EU Novel Food Regulation 2015/2283: Supplement Authorisation Deep-Dive
EU Novel Food readiness for supplements — Regulation 2015/2283 scope, history-of-consumption cutoff (15 May 1997), authorisation dossier, EFSA scientific evaluation, traditional-food-from-third-country notification and Union List management.
EU PPWR & Extended Producer Responsibility: Supplement Packaging Readiness
EU Packaging and Packaging Waste Regulation (PPWR) and Extended Producer Responsibility (EPR) — recyclability, recycled content, minimisation, EPR registration per member state, and supplement packaging design for 2030 and 2040 targets.
Food Allergen Control & FALCPA
Practical guide to allergen control for food manufacturers — the Big 9 under FALCPA + FASTER Act, label declaration, precautionary allergen labelling (PAL), cleaning validation, line clearance and changeover verification.
GCC Saudi SFDA Supplements Readiness: Health Food Registration and Halal
GCC supplements — Saudi SFDA health food registration, GHC harmonisation, halal requirements, Arabic labelling, and the GCC regional entry strategy.
GCC Unified Supplement Regulation: SFDA, MoHAP & Gulf-Wide Market Entry
GCC supplement market readiness — Saudi SFDA Health & Dietary Supplements, UAE MoHAP/Dubai Municipality, GCC Standardisation Organization (GSO) harmonised standards, Arabic labelling, halal certification and importer-of-record discipline.
Gummy & Softgel Supplement Manufacturing Controls: Dosage Form-Specific GMP
Gummy and softgel supplement manufacturing controls — content uniformity, water activity, gelatin vs pectin matrix, encapsulation seal integrity, dissolution and label-claim retention through shelf life.
Gummy Supplement Manufacturer Selection: Water Activity, Pectin vs Gelatin, Potency Holding
Selecting a US or UK gummy supplement contract manufacturer — pectin vs gelatin chemistry, water activity (aw) shelf-life modelling, potency holding for labile actives, depositor vs starch-mogul lines, and the 21 CFR 111 / NSF 173 audit overlay.
Heavy Metals Control for Supplements: USP <232>/<233> and ICP-MS
Heavy metals control for supplements — USP <232> elemental impurities limits, ICP-MS testing under USP <233>, Prop 65 lead reality and supplier sourcing.
ICH Q1A Stability Testing for Supplements: Long-Term, Accelerated and Shelf-Life
Stability testing for dietary supplements — ICH Q1A(R2) framework, long-term and accelerated conditions, climatic zones, stability-indicating methods and shelf-life justification.
India FSSAI Nutraceutical Readiness: 2022 Amendments and the Health Supplement Regime
India supplements — FSSAI nutraceutical regulations 2022, FSS Act health supplements category, license vs registration, and the dual ingredient and claim positive list.
Israel MoH Supplement, Food & Medical Device
Israel readiness — Ministry of Health Food Service supplement notification, Public Health Regulations (Food)(Food Supplements) 1997, AMAR medical device registration, kosher labelling discipline and Hebrew/Arabic labelling rules.
Japan Functional Food Readiness: FFC, Tokuho and Nutrient Function Claims
Japan supplements — the three-track CAA functional food framework: FFC (Foods with Function Claims), Tokuho (FOSHU), and Foods with Nutrient Function Claims.
Latin America Supplement Readiness: Mercosur, Pacific Alliance & National Regimes
Latin America supplement readiness — Mercosur (Argentina, Brazil, Paraguay, Uruguay), Pacific Alliance (Chile, Colombia, Mexico, Peru), national regulatory regimes, Spanish/Portuguese labelling and regional registration discipline.
Mexico COFEPRIS Supplement Deep-Dive: Suplementos Alimenticios & Remedios Herbolarios
Mexico COFEPRIS supplement readiness — Suplementos Alimenticios vs Remedios Herbolarios vs Medicamentos Herbolarios classification, NOM-051 labelling, front-of-pack warning seals, importer-of-record and Spanish-language artwork discipline.
Mexico COFEPRIS Supplements Readiness: Suplementos Alimenticios Notification
Mexico supplements — COFEPRIS suplementos alimenticios notification, ingredient limits under the RCSPS, Spanish labelling and the NOM-051 nutrition table.
Microbiome & Postbiotic Supplement Formulation: Strain ID, ISAPP & Stability
Microbiome and postbiotic supplement formulation playbook — strain-level identity (WGS, MLST), ISAPP postbiotic definition discipline, prebiotic/synbiotic substantiation, CFU and metabolite stability, label claim controls and regulatory positioning.
Minor Cannabinoids & Nootropics: CBG, CBN, Delta-8, Racetams & Adaptogens
Minor cannabinoid and nootropic supplement positioning — CBG, CBN, CBC, delta-8/10 THC isomers, hemp-derived semi-synthetics, racetam family, prescription-only nootropics, adaptogen claim substantiation and cross-market regulatory boundaries.
New Dietary Ingredient (NDI) Notifications under DSHEA: 75-Day FDA Filing
NDI notifications under DSHEA — pre-DSHEA grandfather list, 75-day FDA filing, reasonable expectation of safety, 2016 draft guidance, master file strategy, and the FDA's enforcement posture on unnotified NDIs.
Nitrosamine Risk Control in Supplements: NDMA, NDEA & ICH M7 Risk Assessment
Nitrosamine risk control in dietary supplements — NDMA, NDEA, NMBA formation pathways, ICH M7 (R2) framework, AI thresholds, supplier risk assessment, analytical strategy by LC-MS/MS.
NSF 173 & USP <2750> Readiness: Third-Party Supplement Certification
NSF/ANSI 173 and USP <2750> are the de facto market-access certifications for dietary supplements at major retailers. This guide maps the audit pack a brand needs and how it reuses 21 CFR 111 evidence.
NSF/ANSI 455-2 GMP Readiness: The Retailer-Accepted Supplement Certification
NSF/ANSI 455-2 — the supplement GMP certification retailers and big-box buyers ask for, built on 21 CFR 111 with the audit rigour of a third-party scheme.
Organic, Non-GMO, Halal & Kosher Supplement Certifications: Chain-of-Custody
Organic (USDA NOP, EU), Non-GMO Project Verified, Halal (JAKIM, IFANCA, ESMA) and Kosher (OU, OK, KOF-K, Star-K) supplement certifications — chain-of-custody, audit, ingredient sourcing and label control.
Pet Supplements & NASC Quality Seal: AAFCO, CVM, Xylitol and Lifecycle Controls
Pet supplement readiness — NASC Quality Seal, AAFCO ingredient definitions, FDA-CVM jurisdiction, xylitol toxicity, species-specific dosing, claim substantiation and pharmacovigilance for companion-animal products.
Probiotic CFU Stability & Strain Identity for Supplements: Label Claim Defence
Probiotic CFU stability and strain identity for supplements — strain-level identification by whole-genome sequencing, CFU enumeration overage strategy, water activity control, and ICH-aligned stability for the labelled end-of-shelf-life count.
Prop 65 Supplements Readiness: California Warnings, Lead, Heavy Metals
Prop 65 for supplements — California Safe Drinking Water and Toxic Enforcement Act warnings, the lead threshold reality, heavy-metal sourcing and the bounty-hunter risk.
Medical Foods, Rare Disease & Orphan Supplements: 21 CFR 101.9(j)(8) & EU FSMP
Medical food and orphan supplement positioning — US 21 CFR 101.9(j)(8) medical food exemption, FDA Orphan Products Grants, EU Food for Special Medical Purposes (FSMP) Regulation 609/2013, inborn errors of metabolism formulations and the prescriber-supervised supply chain.
Russia & EAEU TR CU 021/2011 Supplement & Food
EAEU readiness for supplements and food in Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan — TR CU 021/2011 food safety, TR CU 022/2011 labelling, TR TS 027/2012 specialised foods (BAA) and Rospotrebnadzor state registration.
Self-GRAS vs FDA-Notified GRAS for Supplement & Food Ingredients
Self-GRAS vs FDA-notified GRAS — 21 CFR 170.30 criteria, expert panel composition, scientific dossier structure, FDA GRAS Notification Program (GRN), and where supplement ingredients fit vs NDI notifications.
Softgel Supplement Manufacturer Selection: Fill-Shell Compatibility, Cross-Linking, BSE/TSE
Selecting a US or UK softgel supplement contract manufacturer — fill-shell compatibility, gelatin cross-linking and dissolution failure, BSE/TSE source documentation, fish-oil oxidation control (TOTOX), and the 21 CFR 111 / NSF 173 audit overlay.
Sports Nutrition Dosage Forms: Protein, Pre-Workout, EAA, Creatine Manufacturing
Sports nutrition dosage-form playbook — whey/plant protein blending, pre-workout stimulant load, EAA/BCAA hygroscopicity, creatine monohydrate particle size, banned-substance contamination control and WADA-list testing.
Sports Supplement Certification: NSF Certified for Sport, Informed Sport & BSCG
Sports supplement certification — NSF Certified for Sport, Informed Sport, and BSCG programmes compared. WADA Prohibited List screening, lot-by-lot testing, facility GMP audits and athlete-safe label defence.
Sterile & Aseptic Supplement Formats: IV Vitamins, Ophthalmic & Inhalation
Sterile and aseptic supplement format readiness — the drug/supplement boundary for IV vitamins, ophthalmic, nasal and inhalation products, EU GMP Annex 1, USP <797>/<800>, compounding versus manufacturing and the regulatory positioning trap.
Structure/Function Claims Readiness: DSHEA §6, Disclaimers & Substantiation
Structure/function claims under DSHEA §6 require a 30-day FDA notification, a mandatory disclaimer, and a substantiation file. This guide maps the claim-vs-disease line and the evidence FDA and FTC expect.
Structure/Function Claims Readiness: DSHEA Boundary and Substantiation
Structure/function claims for supplements — DSHEA 403(r)(6) boundary, the FTC substantiation standard, the FDA 30-day notification and the disease-claim line.
Supplement Adverse Event Reporting (AER): Serious AER Mandate & MedWatch 3500A
Supplement adverse event reporting — DSNDCPA mandate, serious AER 15-day rule, MedWatch 3500A form, CFSAN Adverse Event Reporting System (CAERS), trending, signal detection, and the brand-owner intake workflow.
Supplement AER Readiness: DSHEA Title II Serious Adverse Event Reporting
DSHEA Title II requires supplement manufacturers, packers and distributors to report serious adverse events to FDA within 15 business days via MedWatch 3500A. This guide maps the clock and the evidence chain.
Supplement Claims Substantiation: FTC, EFSA Article 13, ASA & Global Frameworks
Supplement claims substantiation — FTC competent and reliable scientific evidence standard, EFSA Article 13 health claims, UK ASA/CAP code, Health Canada NHP claims, and the multi-jurisdiction evidence dossier.
Supplement Contract Manufacturer Audit Checklist: 21 CFR 111 + NSF 173 in One Pack
The end-to-end audit checklist for vetting a US dietary supplement contract manufacturer — 21 CFR 111 Subparts A–P, NSF/ANSI 455-2 and USP <2750> bolt-ons, the documents to demand on day one, and the 12 red flags that mean walk away.
Supplement E-commerce Platform Compliance: Amazon, Shopify, TikTok Shop & Marketplace Rules
Supplement e-commerce compliance — Amazon Brand Registry and supplement category restrictions, Shopify supplement merchant requirements, TikTok Shop policies, Meta and Google ad rules, marketplace adverse event intake and claim moderation.
Supplement Identity Testing Readiness: 21 CFR 111 Subpart E
21 CFR 111.75 requires in-house identity verification on every incoming dietary ingredient lot. This guide maps the test methods, validation evidence, and supplier qualification FDA expects under Subpart E.
Supplement Pharmacovigilance: Signal Detection, Causality & Risk Management Plans
Supplement pharmacovigilance — signal detection from AER, causality assessment (WHO-UMC, Naranjo), periodic safety update reports, risk management plans, and lifting pharmaceutical PV discipline into the supplement industry.
Supplement Supply Chain Resilience: Dual-Source Qualification & Geopolitical Risk
Supplement supply chain resilience — dual-source ingredient qualification, geopolitical concentration risk (China, India), commodity price volatility, climate and biodiversity disruption, and the resilience operating playbook.
Supplement Third-Party Testing Compared: NSF 173 vs USP <2750> vs Informed Choice vs ConsumerLab
Comparing the third-party supplement testing & certification schemes brand-owners actually use — NSF/ANSI 173 (455-2), USP <2750>, NSF Certified for Sport, Informed Choice / Informed Sport, BSCG, ConsumerLab — scope, retailer recognition, cost, audit cadence and which to pick.
Switzerland Swissmedic & FOPH Supplements: Food Supplement vs Medicine Boundary
Switzerland supplement readiness — FOPH food supplement regulation under FSO/FCSO, Swissmedic medicine boundary, cantonal enforcement, German/French/Italian trilingual labelling and lifecycle controls.
Traditional Medicine Frameworks: TCM, Ayurveda AYUSH, Kampo & Western Botanical
Traditional medicine supplement readiness — Traditional Chinese Medicine (TCM) under NMPA, Ayurveda under India AYUSH, Japanese Kampo under PMDA, Western Herbal Medicine under EU THMPD and global cross-market traditional-use evidence frameworks.
Turkey TİTCK & Tarım Bakanlığı Supplement & Pharma Readiness
Turkey readiness — Tarım ve Orman Bakanlığı supplementary food (takviye edici gıda) notification, TİTCK medicinal product authorisation, halal/helal certification, Turkish labelling discipline and customs clearance.
UK Food Supplements Readiness: FSA, GB NHCR and Post-Brexit Divergence
Post-Brexit UK food supplements — Food Supplements (England) Regulations 2003, FSA enforcement, GB NHCR and the Windsor Framework GB/NI split.
UK Supplement Brand Launch Compliance Pack: Food Supplements Regs 2003, FIR, CAP/ASA, Primary Authority
Launching a dietary supplement brand in the UK — the Food Supplements (England) Regulations 2003, FIR 1169/2011, GB Nutrition & Health Claims Register, CAP Code & ASA, MHRA borderline-medicines line, Primary Authority partnership and post-Brexit Novel Food authorisation.
US State EPR for Packaging: California SB 54, Oregon, Colorado, Maine & Washington
US state Extended Producer Responsibility for packaging — California SB 54, Oregon Plastic Pollution & Recycling Modernization Act, Colorado HB22-1355, Maine LD 1541, Washington — producer registration, PRO fees, recyclability standards and supplement implications.
USP <2750> Readiness: Manufacturing Practices for Dietary Supplements
USP <2750> Manufacturing Practices for Dietary Supplements — the compendial best-practice chapter above 21 CFR 111, paired with USP Dietary Supplement Verified.
USP Dietary Supplement Verified Program: Mark, Monograph & Audit Readiness
USP Dietary Supplement Verified Program — USP-NF monograph compliance, identity/potency/purity testing, GMP facility audit, the USP Verified Mark, and how it differs from NSF and 21 CFR 111 baseline compliance.
Vegan, Vegetarian, Kosher & Halal Supplement Formulation Playbook
Vegan, vegetarian, kosher and halal supplement formulation playbook — capsule shell selection, vitamin D3/K2/B12 source verification, gelatin alternatives, stearate and excipient screening, chain-of-custody and certification controls.
Women's Health & Prenatal Supplements: Folate, Iron, Iodine & Teratogenicity Controls
Prenatal and women's health supplement readiness — folic acid vs 5-MTHF, iron and iodine specifications, vitamin A teratogenicity ceilings, heavy metal limits below baseline, contraindicated botanicals and pharmacovigilance.
Cannabis & Hemp
State cannabis GMP, hemp/CBD, testing and child-resistant packaging.
Cannabis Labeling & Child-Resistant Packaging
Cannabis labeling and child-resistant packaging — per-state label content, universal symbols, ASTM D3475 / 16 CFR 1700 child-resistant closures, warning statements, serving and dosage rules, and Health Canada plain-packaging.
Cannabis Laboratory Testing & CoA
Cannabis lab testing and CoA — ISO 17025 accreditation, potency (THC/CBD), pesticides, heavy metals, microbial, mycotoxin and residual solvents — action limits, sampling, retesting and remediation across state and federal frameworks.
US Cannabis State GMP
Readiness guide for licensed cannabis cultivators, manufacturers and processors — state GMP rules (FOCUS, ASTM, AHPA), seed-to-sale, testing, recall and inspection.
Cannabis Traceability & Recall
Practical guide to cannabis traceability and recall — METRC and equivalent systems, ASTM D8434 safety standards, state recall rules, complaint handling and adverse event reporting.
USDA Hemp THC Compliance
USDA Domestic Hemp Production Program (7 CFR Part 990) readiness — 0.3% delta-9 total THC limit, DEA-registered laboratories, sampling windows, disposal and remediation, negligence thresholds and state hemp plan alignment.
Pharma & GxP
Drug manufacturing, distribution and electronic records.
10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
10 CFR Part 35 medical-use licensing for radiopharmaceutical sites: Authorized User, Radiation Safety Officer, written directives, Lu-177 and I-131 therapy, dose-administration recordkeeping, and Agreement State variations.
21 CFR 211 Drug cGMP
Plain-English guide to 21 CFR Part 211 — current Good Manufacturing Practice for finished pharmaceuticals. Subparts B through K, data integrity, ALCOA+, and an FDA inspection-ready path.
21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
FDA 21 CFR Part 212 cGMP for PET drugs: personnel, facilities, components, production, lab controls, conditional release under 212.70(f), and the 90-day path from cyclotron commissioning to PAI.
21 CFR 589 BSE / Ruminant Feed Ban
Operating manual for the FDA BSE-prevention feed regulation — 21 CFR 589.2000 and 589.2001, prohibited cattle materials, segregation and labelling controls.
21 CFR Part 11
Plain-English guide to FDA 21 CFR Part 11 — electronic records, electronic signatures, audit trails, and a practical path to a Part 11-compliant eQMS without theatre.
Australia pharmaceutical GMP readiness — TGA, PIC/S GMP, ARTG
TGA regulation, Therapeutic Goods Act, PIC/S GMP adoption, ARTG listing, manufacturing licence and GMP clearance, EU–AU MRA, and a readiness path.
Radiopharmaceutical conditional batch release — operating model
Conditional / parametric batch release for short-lived radiopharmaceuticals: 21 CFR 212.70(f), EU Annex 3, PIC/S PE 010, parametric controls, post-release sterility, patient-notification call tree, and audit trail.
Brazil pharmaceutical GMP readiness — ANVISA, RDC 658/2022, CBPF, SNCM
ANVISA regulation, RDC 658/2022 GMP (replacing RDC 301/2019), CBPF certification, SNCM serialization, language and dossier requirements, and a readiness path.
Canada pharmaceutical GMP readiness — Health Canada, FDR Div. 2, DEL
Health Canada / HPFB regulation, Food and Drug Regulations Division 2, Drug Establishment Licence, EU–Canada MRA, GUI-0001, and a 90–180 day readiness path.
CAR-T Cell Therapy Manufacturing
Readiness guide for CAR-T and gene-modified cell therapy manufacturers — 21 CFR 211 GMP, 21 CFR 1271 starting material, FACT-JACIE handoff, chain of identity and the commercial sponsor relationship.
China pharmaceutical GMP readiness — NMPA, Drug Administration Law, 2010 GMP
NMPA regulation, Drug Administration Law, 2010 GMP and revised annexes (including data integrity), MAH system, drug code serialization, and a 90–180 day readiness path.
DSCSA
Plain-English guide to the Drug Supply Chain Security Act (DSCSA) — serialization, aggregation, EPCIS exchange, verification, and the path through enhanced drug distribution security.
Electronic Batch Record (eBR) Explained
Plain-English guide to electronic batch records — what an eBR is, the regulatory drivers, what makes one defensible, and how a live eBR collapses release time from days to hours.
Electronic Batch Record (EBR) System
Plain-English readiness guide for electronic batch records — 21 CFR Part 11 / EU GMP Annex 11 compliance, MBR vs EBR, review-by-exception, exception management, and the path off paper.
EU Falsified Medicines Directive
Plain-English guide to the EU Falsified Medicines Directive 2011/62/EU and Delegated Regulation 2016/161 — unique identifier, tamper-evident features, EMVS connection and the path to clean dispense-time verification.
EU GDP
Plain-English guide to EU Good Distribution Practice (2013/C 343/01) — Responsible Person duties, temperature control, qualifications, falsified medicines, and inspection.
EU GMP Annex 1 Sterile Manufacturing
Plain-English guide to the 2022 revision of EU GMP Annex 1 — sterile medicinal products. Contamination Control Strategy, QRM, grade A/B/C/D, barrier technology and aseptic process simulation.
EU GMP Annex 11
A practical, audit-ready walkthrough of EU GMP Annex 11 — what each clause means, what inspectors look for, and how to evidence compliance for any GxP system.
EU GMP for Medicinal Cannabis
EU GMP readiness for medicinal cannabis cultivators, extractors and finished-product manufacturers — Part I, Annex 7 (herbal), Annex 1 (sterile), QP release and EU-GMP certification.
EU pharmaceutical GMP readiness — EudraLex Vol 4, QP release, EU GDP
EudraLex Vol 4 Part I/II, Annexes (1, 11, 15, 16), Qualified Person batch certification, EU GDP, FMD serialization, EMA/national-competent-authority inspections, and a readiness path.
Ga-68 generator elution readiness — DOTATATE and PSMA imaging ops
Ga-68 generator elution operations for Ga-68-DOTATATE and Ga-68-PSMA-11 imaging: breakthrough testing, hot-cell ops, automated synthesizer integration, release controls, and EOS / EOL generator change-out.
GAMP 5 & FDA CSA
Plain-English guide to GAMP 5 second edition and FDA's Computer Software Assurance — software categories, risk-based testing, intended use, and a leaner validation pack.
GCC pharmaceutical GMP readiness — Saudi SFDA, GCC-DR, UAE MOHAP, RSD
Saudi SFDA, GCC Drug Registration, UAE MOHAP, Kuwait/Qatar/Oman/Bahrain regulators, PIC/S alignment, Saudi RSD serialization, and a 90–180 day readiness path.
Global pharmaceutical GMP readiness — ICH, PIC/S, and country roll-up
How ICH Q7/Q9/Q10 and PIC/S align cGMP across FDA, EU, MHRA, PMDA, Health Canada, TGA, ANVISA, NMPA, MFDS, Swissmedic, CDSCO, and GCC — with a pragmatic readiness path.
ICH E6(R3) Good Clinical Practice
Plain-English guide to ICH E6(R3) — the 2025 revision of Good Clinical Practice. Quality by design, fit-for-purpose, risk-proportionate oversight, sponsor and investigator duties, computerised systems Annex 2, and a defensible GCP programme for FDA, EMA, MHRA, PMDA and Health Canada inspections.
ICH Q10 Pharmaceutical Quality System
Plain-English guide to ICH Q10 — the global Pharmaceutical Quality System. Management responsibilities, lifecycle stages, enablers, and a practical implementation path.
ICH Q7 API GMP
Plain-English guide to ICH Q7 — Good Manufacturing Practice for Active Pharmaceutical Ingredients. Process step boundaries, the API starting material, change control and the FDA/EMA expectations.
ICH Q8, Q11 & Q12
Plain-English guide to ICH Q8(R2), Q11 and Q12 — Quality by Design, design space, control strategy, Established Conditions and Post-Approval Change Management Protocols (PACMPs). Built for QA, regulatory affairs and process development leads at pharma and biotech.
ICH Q9(R1) Quality Risk Management
Plain-English guide to ICH Q9(R1) — the international standard for Quality Risk Management in pharmaceuticals. Subjectivity, formality, hazard ID, and a QRM programme inspectors trust.
India pharmaceutical GMP readiness — CDSCO, Schedule M, Drugs and Cosmetics Act
CDSCO regulation, Drugs and Cosmetics Act 1940, revised Schedule M (2023, mandatory phased in 2024–2025), state licensing, export GMP, and a readiness path.
Japan pharmaceutical GMP readiness — PMDA, MHLW, J-GMP, MF
PMDA and MHLW regulation, PMD Act, Japanese GMP Ordinance, Marketing Authorization Holder model, accredited foreign manufacturer registration, and a readiness path.
Lu-177-PSMA manufacturing readiness — theranostic GMP playbook
Lu-177-PSMA (Pluvicto / 177Lu-PSMA-617) manufacturing under 21 CFR 211 and EU Annex 3: n.c.a. vs c.a. Lu-177 supply, peptide labeling, radiochemical purity, dose-on-demand vs centralized, and conditional release.
Radiopharmaceutical manufacturing — the global readiness hub
A practical operator's hub for radiopharmaceutical manufacturing: 21 CFR 212, USP <825>, 10 CFR 35, EU GMP Annex 1/3, Lu-177 / Ga-68 / PET ops, conditional release, batch genealogy, and theranostics scale-up.
South Korea pharmaceutical GMP readiness — MFDS, KGMP, serialization
MFDS regulation, Pharmaceutical Affairs Act, KGMP alignment with PIC/S, MAH-equivalent licensing, drug serialization, and a 90–180 day readiness path.
Switzerland pharmaceutical GMP readiness — Swissmedic, TPA, QP release
Swissmedic regulation, Therapeutic Products Act, PIC/S-aligned GMP, QP release, EU MRA, GDP, and a 90–180 day readiness path.
UK pharmaceutical GMP readiness — MHRA, UK GMP, QP release, UK GDP
MHRA regulation, UK GMP (PIC/S-aligned), QP/RPi release, UK GDP, FMD legacy and UK serialization plans, MHRA inspection style, and a 90–180 day readiness path.
USA pharmaceutical GMP readiness — FDA 21 CFR 210/211 and DSCSA
FDA cGMP for finished drugs (21 CFR 210/211), API cGMP via ICH Q7, DSCSA serialization, PAI patterns, 483/Warning Letter risk, and a 90–180 day readiness path.
USP <797> Sterile Compounding
Plain-English guide to USP General Chapter <797> — pharmaceutical compounding of sterile preparations. Category 1, 2 and 3 CSPs, the BUDs, the cleanroom design, and a path to a clean state-board inspection.
USP <825> radiopharmaceutical compounding readiness — practical playbook
USP General Chapter <825> for radiopharmaceutical compounding, dispensing, and repackaging: BUDs, immediate-use rules, hot-cell design, cleanroom alternatives, and the readiness gaps state boards inspect first.
Veterinary Pharma Manufacturing Readiness: The V5 Hub
Hub guide for veterinary pharmaceutical and biologic manufacturers — FDA-CVM (21 CFR 514 NADA/ANADA), USDA-APHIS (9 CFR 113 veterinary biologics), VFD medicated feed, VICH international harmonisation and AMDUCA extralabel discipline.
Medical Devices & IVD
Device QMS, technical documentation and software lifecycle.
21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
Clause-by-clause mapping between FDA 21 CFR Part 820 (QSR / QMSR) and ISO 13485:2016 — what harmonises after February 2026, where the two still diverge, and what to fix in your QMS before the QMSR effective date.
FDA 510(k) Clearance
Plain-English readiness guide for FDA 510(k) Premarket Notification — predicate selection, eSTAR submission, RTA pre-check, MDUFA V timelines, AI-NAI hold cycles, and the path to a clean substantial-equivalence decision.
AI/ML Medical Device Readiness: FDA PCCP + EU AI Act, In One Plan
Practical readiness guide for AI/ML-enabled medical devices — FDA's December 2024 PCCP final guidance, the EU AI Act layered on top of MDR/IVDR, and a unified QMS plan that satisfies both.
Australia medical device regulatory
TGA/ARTG pathway with Essential Principles, Schedule 3 conformity assessment, MDSAP use, UDI rollout, Sponsor duties, PMS and IVD/SaMD specifics for Australia
Brazil medical device regulatory
Technical roadmap to obtain and sustain ANVISA market access for medical devices in Brazil, covering RDC 751/2022, RDC 665/2022, Cadastro/Registro, BRH, INMETRO, PMS and.
Canada medical-device regulatory
Technical roadmap to Health Canada medical-device licensing, MDSAP, QMS expectations, bilingual labelling, UDI rollout, PMS, and review timelines in Canada
China medical device regulatory
Deep, current guidance for medical device manufacturers to achieve and maintain NMPA market access in China, including CMDE review, type testing, UDI and PMS
eDHR Implementation Guide for Medical-Device Manufacturers
A practical, phased guide to implementing an electronic Device History Record system — DMR lock, calibrated-tool integration, UDI at the workstation, IEC 62304 linkage, and a 90-day rollout that survives an FDA inspection.
EU IVDR
Plain-English guide to Regulation (EU) 2017/746 — the In Vitro Diagnostic Regulation. Risk classes, performance evaluation, notified body involvement, and a path through the transition deadlines.
EU MDR Technical Documentation
Plain-English guide to EU MDR technical documentation — Annex II device file, Annex III post-market surveillance, GSPR, clinical evaluation, and notified-body review.
EU MDR medical device regulatory readiness (European Union)
A technical, step-by-step guide to achieve and maintain EU MDR (Regulation (EU) 2017/745) compliance, from classification and NB audits to UDI, PMS and vigilance
FDA QMSR Transition Guide: 21 CFR 820 to ISO 13485
Plain-English guide to FDA's Quality Management System Regulation (QMSR) — what changes from 21 CFR 820, what 13485 brings in, and how to transition by 2 February 2026.
GCC Medical Device Readiness: Saudi Arabia & UAE
Technical guide to SFDA and UAE MOHAP device regulation, classification, approvals, QMS, UDI, labelling, vigilance, and a 90–180 day readiness plan
Global medical device regulatory readiness (2026)
A master hub for RA/QA leaders to plan ISO 13485 QMS, multi-country clearances, MDSAP, and post‑market duties (UDI, vigilance, registries) across major markets
IEC 62304 Medical Device Software
Plain-English guide to IEC 62304 — the lifecycle standard for medical device software. Safety classes, SOUP, problem resolution, and a software file that survives audit.
India Medical Device Regulatory
Deep technical guide to CDSCO, MDR 2017, device classification, licensing, QMS, labeling, vigilance, and a 90–180 day plan for India
ISO 13485
Plain-English guide to ISO 13485:2016 — the QMS standard for medical devices. Scope, process approach, risk, design controls, and a realistic certification path.
ISO 14971 Risk Management
Plain-English guide to ISO 14971:2019 — the risk management standard for medical devices. Hazards, harms, risk control, residual risk, and a living risk management file.
Japan medical-device regulatory
A technical, step-by-step guide for RA/QA leaders on PMDA/MHLW pathways, QMS, UDI, GVP vigilance, and approval strategies for medical devices in Japan
MDSAP
Plain-English guide to the Medical Device Single Audit Program — one audit, five regulators (US, Canada, Brazil, Australia, Japan). Audit model, grading, country-specific add-ons, and a path to a clean report.
Software as a Medical Device (SaMD)
Plain-English readiness guide for Software as a Medical Device — IMDRF framework, FDA / EU MDR / UK MHRA expectations, IEC 62304 lifecycle, AI/ML PCCP, cybersecurity, and a 120-day path to a clean submission.
South Korea medical device regulatory
Deep, current guide to MFDS rules, KGMP, UDI, approvals, and post‑market duties for medical device manufacturers entering South Korea
Switzerland: Medical Device Regulatory
A technical, current guide to Swissmedic, MedDO/IvDO, CH-REP, UDI, PMS, and Swiss market entry for medical devices
United Kingdom medical device regulatory readiness (UK)
Technical guide to MHRA, UK MDR 2002, UKCA/CE in GB, NI under EU MDR, DORS/UDI plans, PMS/vigilance via MORE, and a 90–180 day readiness path
UK UKCA Medical Device Transition
How medical device manufacturers comply with the UK Medical Devices Regulations 2002 (as amended), the UKCA / CE acceptance transition timelines, MHRA registration via DORS and the future UK Medical Devices Regulations reform.
United States medical device regulatory
A deep, current guide for RA/QA leaders on preparing medical devices for US FDA market access, from classification to QMSR, eSTAR, UDI/GUDID, and MDR
Food Safety
HACCP, GFSI schemes, FSMA traceability and meat/poultry rules.
9 CFR 113 Veterinary Biologics
Readiness guide for USDA-APHIS Center for Veterinary Biologics manufacturers under 9 CFR 101–124 — licensed biologics, autogenous vaccines, outline of production, serial release and post-licensure obligations.
9 CFR 416 SSOP
Operating manual for 9 CFR 416 sanitation — daily pre-op and operational SSOPs, sanitary dressing, Listeria control, and the IIC verification that drives more FSIS NRs than HACCP.
9 CFR 430 Listeria
Operating manual for 9 CFR 430 — Alternative 1, 2 and 3 choice, post-lethality treatment, antimicrobial agents, FSIS verification swabs and EMP density for RTE meat and poultry.
Acrylamide Mitigation Readiness: EU 2017/2158 Benchmark Levels
Practical guide to acrylamide mitigation under EU Regulation 2017/2158 — benchmark levels for bakery, cereal, coffee, potato and infant foods, the mandatory mitigation measures, sampling plan, and how this aligns with FDA 2016 guidance and Codex CXC 67-2009.
Australia & New Zealand Supermarket Supplier Standards:
How manufacturers stack WQA, HARPS, BRCGS or SQF and retailer codes to win private-label listings at Woolworths, Coles, ALDI, IGA and the NZ Foodstuffs co-ops.
BRCGS Food Safety Issue 9
Plain-English guide to BRCGS Global Standard for Food Safety Issue 9 — fundamentals, HACCP, food safety culture, unannounced audits, and a path to AA grade.
TTB Readiness for Breweries & Distilleries — 27 CFR 25 / 19 Guide
What TTB actually asks for at a brewery (27 CFR 25) or distilled spirits plant (27 CFR 19) — records, reports, formulas, inventory, and how to be audit-ready without paper.
California Proposition 65 Warning
Plain-English guide to California Proposition 65 — OEHHA listed substances, safe-harbor warnings, the 2025 short-form rule, online and catalog disclosures, and bounty-hunter litigation defence.
Canada Supermarket Supplier Standards:
How Canadian manufacturers stack SQF or BRCGS, CanadaGAP and SFCR to win private-label listings at Loblaw, Sobeys, Metro, Walmart Canada and Costco Canada.
Food Fraud (VACCP) & Food Defense (TACCP)
Practical guide to food fraud vulnerability assessment (VACCP) and food defense threat assessment (TACCP) for GFSI compliance — economically motivated adulteration, intentional contamination, FSMA 121, mitigation strategies.
Food Processing cGMP Readiness: The V5 Hub
Hub guide for food manufacturers — FSMA preventive controls (21 CFR 117), FSMA 204 traceability, the GFSI schemes (SQF, BRCGS, FSSC 22000, IFS), HACCP, allergen control, EMP, food fraud and sanitary design — on one QMS spine.
France Supermarket Supplier Standards:
How French food manufacturers stack IFS Food, Label Rouge, AOP, AB and EGalim rules to win own-brand listings at Carrefour, Leclerc, Intermarché, Auchan and Casino.
FSIS Appendix A Lethality
Operating manual for FSIS Appendix A — validated cook time-temperature combinations, humidity, come-up-time, deviation handling and the 2021 update for cooked RTE meat and poultry.
FSIS Appendix B Stabilization & Cooling
Operating manual for FSIS Appendix B — cooling curve compliance for Clostridium perfringens and botulinum control, deviation handling, and what the IIC checks on the cool record.
FSIS Label Approval
Operating manual for FSIS label approval — generic vs sketch approval under 9 CFR 412, special-statement claims, allergen and nutrition rules, and the LPDS submission path.
FSIS Meat & Poultry HACCP
Operating manual for USDA-FSIS HACCP in meat and poultry — 9 CFR 417 hazard analysis, 9 CFR 416 SSOP, Appendix A/B lethality and stabilization, recall, and what an IIC actually checks.
FSMA 204 Food Traceability
Plain-English guide to FDA FSMA Section 204 — the Food Traceability List, Key Data Elements, Critical Tracking Events, and how to be 24-hour-ready before the January 2026 deadline.
FSMA Preventive Controls & PCQI
Plain-English guide to FSMA Preventive Controls for Human Food (21 CFR 117) — the food safety plan, hazard analysis, PCQI duties, and a realistic readiness path.
FSSC 22000
Plain-English guide to FSSC 22000 v6 — ISO 22000, sector PRPs, and the additional FSSC requirements that auditors actually focus on during certification.
FSVP Readiness Checklist 2026: 7 Things FDA Inspects First
What FDA actually opens first in an FSVP inspection — the 7 records, signatures, and verification activities every US food importer needs on file in 2026.
Germany & DACH Supermarket Supplier Standards:
How food manufacturers stack IFS Food, QS, KAT and retailer codes (Edeka, Rewe, Aldi, Lidl, Kaufland) to win own-brand listings across Germany, Austria and Switzerland.
The Global Supermarket Supplier Standards Playbook
A practical hub for QA and technical leaders on how supermarket own-brand standards work globally—three-layer stack, regional schemes, laws, and cross-border strategy.
HACCP Codex
Plain-English guide to HACCP per Codex Alimentarius CXC 1-1969 Rev.5 (2020) — the seven principles, the twelve logic steps, prerequisite programmes and a plan that survives any GFSI audit.
IFS Food Version 8
Plain-English guide to IFS Food Version 8 — the GFSI-recognised standard used across European retail. KO requirements, scoring, unannounced audits and a path to a Higher Level certificate.
Ireland Supermarket Supplier Standards:
How Irish manufacturers stack Bord Bia Origin Green, SBLAS, SDAS and BRCGS to win own-brand listings at Tesco Ireland, Dunnes, SuperValu, Lidl and Aldi — and UK exports.
ISO 22000:2018 Food Safety Management
Plain-English guide to ISO 22000:2018 — the international food safety management standard. PDCA, HACCP, PRPs, the operational PRP concept and a path to a clean certification audit.
Japan & Korea Supermarket Supplier Standards:
How food manufacturers stack JFS-C, FSSC 22000, JAS organic, K-GAP and retailer codes (Aeon, Seven & i, Lotte, Emart) to win own-brand listings in Japan and South Korea.
Meat & Sausage Processing Controls and Traceability Guide
Operating manual for grind-to-pack traceability in meat and sausage processing — formula control, mixer-to-stuffer lot reconciliation, allergen and Listeria controls, FSIS verification readiness.
Meat Traceability Software: USDA, 9 CFR 320 and Mock-Recall Readiness
What meat traceability software has to do — 9 CFR 320 records, two-year retention, FSIS recall drill, lot capture at grind/sausage/case-ready — and how to evaluate vendors.
Netherlands & Belgium Supermarket Supplier Standards:
How food manufacturers stack BRCGS or IFS, Beter Leven, IKB and retailer codes (Albert Heijn, Jumbo, Colruyt, Delhaize) to win own-brand listings in the Benelux.
Nordic Supermarket Supplier Standards:
How food manufacturers stack Svenskt Sigill, KSL, DANISH, Sirkka and BRCGS/IFS to win own-brand listings at ICA, Coop, Salling Group, Norgesgruppen, S-Group and Kesko.
SQF Edition 9 Food Safety
Plain-English guide to the SQF Food Safety Code Edition 9 — system elements, food safety culture, environmental monitoring, unannounced audits and a path to a clean SQF certificate.
UK HFSS Promotion & Placement Restrictions Readiness
How UK food and drink brands comply with the Food (Promotion and Placement) (England) Regulations 2021 — HFSS placement, volume-price promotion restrictions, the Nutrient Profile Model 2004/2005 and the upcoming TV/online advertising ban.
UK Supermarket Supplier Standards: A
How UK food manufacturers stack Red Tractor, BRCGS Issue 9, and retailer-specific codes (Tesco, M&S, Sainsbury's, Waitrose, Morrisons, Asda) to win and keep own-brand listings.
US Supermarket & Retailer Supplier Standards:
How US food manufacturers stack SQF, GAP, Walmart SQEP and FSMA 204 to win private-label listings at Walmart, Kroger, Costco, Whole Foods, Target and Albertsons.
Cosmetics & Personal Care
MoCRA, ISO 22716 cosmetics GMP and consumer product safety.
ASTM F963-23 & EN 71 Toy Safety
Plain-English cross-walk between the US ASTM F963-23 toy safety standard and the EU EN 71 series — mechanical, flammability, chemical, electrical and labelling requirements for toys sold into both markets.
Cosmetic Labeling & Fragrance Allergen Readiness (EU, UK, US)
Plain-English guide to cosmetic labeling under EU 1223/2009 Article 19, UK Schedule 34 and MoCRA Section 609 — INCI, claims under Regulation 655/2013, and the 2023 EU fragrance allergen expansion from 26 to 80+ substances.
Cosmetic Microbiological Quality (ISO 17516)
Plain-English guide to cosmetic microbiological quality — ISO 17516 limits, ISO 21149/16212/18415/22717/22718 test methods, water activity exclusions and environmental monitoring for cosmetics fills.
Cosmetic Stability & Preservative Efficacy (ISO 11930) Readiness
Plain-English guide to cosmetic stability testing and preservative efficacy / challenge testing under ISO 11930 — protocols, acceptance criteria, PAO/Period After Opening and how the dossier links to the PIF and MoCRA safety substantiation.
ISO 22716 Cosmetics GMP
Plain-English guide to ISO 22716 — Good Manufacturing Practices for cosmetics. EU Regulation 1223/2009 link, premises, production, laboratory, internal audits and the path to a clean inspection.
MoCRA
Plain-English guide to the Modernization of Cosmetics Regulation Act — facility registration, product listing, safety substantiation, adverse-event reporting, and GMPs for cosmetics sold in the US.
Veterinary & Animal Health
Animal feed, veterinary biologics and pet food readiness.
Biopesticide & Microbial Registration
Registration readiness for biopesticides under EPA Biopesticide Division, EU low-risk active substances and microbial categories — Bacillus, Trichoderma, baculoviruses and biochemical actives.
Pet Food & Animal Food cGMP
Operating manual for pet food and animal food cGMP — 21 CFR 507, AAFCO Model Regulations, FSMA preventive controls and the disciplines a pet-food plant runs every day.
Veterinary Feed Directive & Medicated Feed
Readiness guide for medicated feed manufacturers and VFD distributors under 21 CFR 225/558 and the Veterinary Feed Directive — feed mill cGMP, VFD recordkeeping, assay and the antimicrobial stewardship overlay.
VICH International Harmonisation
Readiness guide for multi-region veterinary medicinal product submissions under VICH guidelines — GL2 stability, GL9 GCP, GL24/29 pharmacovigilance, GL49 residue methods and MUMS pathways.
International & Regional
Country and regional regulatory readiness across the globe.
Australia AICIS industrial chemicals readiness — introducer obligations
Australian Industrial Chemicals Introduction Scheme (AICIS) under the Industrial Chemicals Act 2019 — registration, six introduction categories, AICIS Inventory, record-keeping, and a readiness path.
Australia APVMA agvet chemicals readiness — registration & manufacturing
Australian Pesticides and Veterinary Medicines Authority (APVMA) — Agvet Code, product registration, active-constituent approval, manufacturing licensing, GMP for veterinary medicines, and a readiness path.
Australia TGA Readiness: AUST L Listed Medicines and PIC/S GMP
Australia regulates supplements as complementary medicines — TGA AUST L listing, Permissible Ingredients, Permitted Indications and PIC/S PE 009 GMP.
Canada NHP Readiness: NNHPD Licensing, NPN and Health Canada GMP
Health Canada NHP regulation — NNHPD Product Licence and NPN, Site Licence, and Part 3 Natural Health Products Regulations GMP enforced via GUI-0048 inspections.
Canada NNHPD Natural Health Products: NPN, Monographs, Site Licence & Claims
Canada Natural Health Products readiness — NNHPD Natural Product Number (NPN), Compendium of Monographs, Product Licence Application (PLA), Site Licence, GMP, labelling and lifecycle controls.
China Health Food Readiness: Blue Hat Registration and CBEC
China supplements — SAMR Blue Hat registration or filing for the domestic Health Food channel and the cross-border e-commerce (CBEC) positive list.
China NMPA Blue Hat & Cross-Border E-Commerce: Supplement Market Entry
China supplement market entry — NMPA Blue Hat (health food) registration and filing pathways, cross-border e-commerce (CBEC) channel via Hainan/Tmall Global/JD Worldwide, ingredient catalogue, claim list and lifecycle controls.
EU 10/2011 Plastics Food-Contact
Readiness guide for plastic food-contact materials under Commission Regulation (EU) 10/2011 — Union List, SML, OML, NIAS, declaration of compliance and supporting documentation.
EU AI Act
Plain-English guide to Regulation (EU) 2024/1689 — the EU AI Act — for pharmaceutical, medical-device and regulated manufacturers. Risk tiers, high-risk AI systems, GMLP, predetermined change control, and how the AI Act stacks on top of GMP, 21 CFR Part 11, Annex 11, GAMP 5 and CSA.
EU Cosmetics Regulation 1223/2009
Plain-English readiness guide to EU Regulation (EC) 1223/2009 — Responsible Person, PIF, CPNP notification, safety assessment, labelling and post-market surveillance.
EU GPSR 2023/988
Plain-English guide to the EU General Product Safety Regulation (2023/988) — responsible economic operator, technical documentation, risk assessment, Safety Business Gateway and online marketplace duties.
EU PPWR
Readiness guide for the EU Packaging and Packaging Waste Regulation (PPWR) — recyclability-by-design grading, minimum recycled content, single-use restrictions and EPR fee modulation.
EU REACH for Agrochemicals
How REACH (EC) 1907/2006 interacts with EU pesticide regulation 1107/2009 — registration boundary, SVHC, authorisation, restrictions and supply-chain documentation for agrochemical manufacturers.
EU REACH Registration for Industrial Chemicals —
Plain-English guide to EU REACH registration for industrial chemicals — tonnage bands, Annex VI–X data, SVHC authorisation, Annex XVII restriction and the Only Representative route.
EU Tissues & Cells Directive 2004/23/EC
Readiness guide for EU tissue and cell establishments — Directive 2004/23/EC, implementing Directives 2006/17 and 2006/86, the SoHO Regulation transition and competent authority inspection.
Global Agrochemical Quality & Compliance
Unified operating model for pesticide and agrochemical manufacturers across US FIFRA, EU 1107/2009, Codex MRLs, FAO/WHO specifications and ISO 17025 — one record spine, many filings.
Global Cannabis Quality & Compliance
Unified cannabis operating model across US state GMP, Health Canada Cannabis Regulations, EU-GMP medicinal cannabis, seed-to-sale traceability, ISO 17025 lab testing, child-resistant packaging and USDA hemp.
Global Consumer Product Safety
One operating model across US CPSIA, EU GPSR 2023/988, California Prop 65, REACH and RoHS — economic operator duties, technical files, conformity and post-market for consumer goods.
Global Cosmetics Regulatory
One operating model across EU 1223/2009, UK Cosmetics Regulation, US MoCRA and ISO 22716 GMP — Responsible Person, PIF, safety substantiation, labelling and post-market.
Global Food-Contact Materials
Unified operating model for food-contact plastics and resins across EU 10/2011, FDA 21 CFR 177, EU 2022/1616 recycled plastics, EU PPWR and emerging PFAS / BPA / phthalate restrictions.
Global Specialty & Industrial Chemicals Quality & Compliance Readiness
Unified operating model for specialty and industrial chemicals — EU REACH, US TSCA, GHS/CLP, OSHA PSM, DOT/ADR hazmat and ATEX on one record spine.
Korea MFDS Health Functional Food: HFF, Functional Ingredients & Generic Approval
Korea supplement market readiness — MFDS Health Functional Food (HFF) framework, functional ingredient list, generic vs individually-approved pathways, GMP and lifecycle compliance for the Korean supplement market.
UK Cosmetics Regulation & SCPN
Plain-English guide to the UK Cosmetics Regulation — UK Responsible Person, SCPN notification, UK PIF, OPSS oversight, divergence from EU 1223/2009 and Northern Ireland under the Windsor Framework.
UK Packaging EPR & Plastic Packaging Tax Readiness
How UK producers comply with the DEFRA Extended Producer Responsibility for packaging (pEPR), the Plastic Packaging Tax (PPT), the upcoming Deposit Return Scheme and Simpler Recycling — replacing the legacy PRN/PERN system.
UK MHRA Clinical Trials Regulations 2024
How UK clinical-trial sponsors comply with the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 — combined review, proportional risk, transparency, diversity and post-Brexit divergence from the EU CTR.
UK Modern Slavery Act §54 statement readiness
Modern Slavery Act 2015 §54 transparency-in-supply-chains statement — threshold, six recommended areas, board approval, government registry, and a readiness path.
UK Natasha's Law & PPDS Allergen Labelling Readiness
How UK food businesses comply with Natasha's Law (PPDS allergen labelling), FIC retained EU law, FSA allergen guidance and the 14 mandatory allergen disclosure framework.
Welsh language & bilingual packaging readiness — Wales & UK retail
Welsh Language (Wales) Measure 2011, Welsh Language Standards, FSA bilingual labelling guidance, retailer-imposed Welsh requirements, and a packaging artwork readiness path for UK brand-owners.
UK Windsor Framework Medicines
How pharmaceutical manufacturers comply with the Windsor Framework UK-wide medicines licensing for human medicines marketed in Northern Ireland — single UK MA via MHRA, UK-only packaging, and divergence from EU centralised procedure.
California SB 253 & SB 261 climate disclosure readiness
California Climate Corporate Data Accountability Act (SB 253) and Climate-Related Financial Risk Act (SB 261) — Scope 1/2/3 GHG reporting, climate risk disclosure, thresholds, timelines, and a readiness path.
US DSCSA 2024 Stabilization & Enhanced Drug Supply Chain Readiness
How US pharmaceutical manufacturers, repackagers, wholesale distributors and dispensers comply with the Drug Supply Chain Security Act 2024 stabilization period and the Enhanced Drug Distribution Security framework — EPCIS, package-level serialisation, verification and saleable returns.
EPA TSCA PFAS Section 8(a)(7) reporting readiness — 40 CFR 705
EPA's one-time PFAS reporting rule under TSCA §8(a)(7) and 40 CFR Part 705 — who must report, the 2011-2022 lookback, data elements, joint submissions, and a readiness path.
US FTC Made in USA & Endorsement Guides Readiness
How US brands comply with the FTC Made in USA Labeling Rule (16 CFR Part 323), the Endorsement Guides (16 CFR Part 255), influencer disclosure and the FTC's negative-option / subscription enforcement.
US TSCA Chemical Inventory & PMN
How US manufacturers and importers comply with the Toxic Substances Control Act — TSCA Inventory, Section 5 PMN/SNUR, Section 8 CDR reporting, Section 6 risk evaluations and the 2016 Frank R. Lautenberg amendments.
US USDA Bioengineered (BE) Food Disclosure Readiness
How US food brands comply with the USDA National Bioengineered Food Disclosure Standard (7 CFR Part 66) — BE List, refining/validation testing, disclosure formats, small-manufacturer pathways and the Non-GMO Project ecosystem.
USDA Organic (NOP) Operator
How US producers, handlers, processors and importers comply with the USDA National Organic Program (7 CFR Part 205), the 2024 Strengthening Organic Enforcement (SOE) rule, the National List, OSP requirements and split-operation discipline.
USP <800> Hazardous Drug Handling
How US healthcare facilities, compounding pharmacies, manufacturers and 503A/503B outsourcing facilities comply with USP General Chapter <800> Hazardous Drugs — Handling in Healthcare Settings.
Software, Data & EBR
MES, EBR, batch traceability and computerised system validation.
Batch Traceability Software: How Batch Genealogy Actually Works
Batch traceability software explained — what batch-level genealogy must capture, how rework and re-blend break ERPs, and how kiosk-led batch records pass an FDA mock recall in minutes.
Calibration Management Program: A Practical Guide
Plain-English guide to calibration management — what a program covers, the regulations behind it, the lifecycle, common audit findings, and how to run it without spreadsheets.
Chemical Traceability Software: Batch, Lot and SDS Chain Across REACH/TSCA
Chemical traceability software explained — batch genealogy, SDS chain, REACH/TSCA/CLP record-keeping, and how to keep raw-material-to-shipment traceable across blending and packaging.
Ingredient Traceability Software: Raw Material to Finished Lot
What ingredient traceability software actually has to capture — supplier lot, CoA, allergen, expiry, weigh-step capture — and how to evaluate it against FSMA 204, 21 CFR 211 and 117.
Lot Traceability Software: The Practical Guide
What lot traceability software actually has to do — bidirectional genealogy, recall drills, FSMA 204 KDEs, 21 CFR 211 components — and how to tell real traceability from an ERP checkbox.
Traceability Software: A 2026 Buyer's Guide
Plain-English buyer's guide to traceability software — what it does, the regulations behind it (FSMA 204, EU 178/2002, UDI, DSCSA), the capabilities that matter, and how to evaluate vendors.
What Is an MES? Manufacturing Execution System Explained
Plain-English guide to Manufacturing Execution Systems — what an MES does, how it differs from ERP and SCADA, where it pays back, and how to pick one in 2026.
What Is a QMS? Quality Management System Explained
Plain-English guide to QMS — what a Quality Management System actually is, the regulations behind it, what an eQMS replaces, and how to evaluate one in 2026.
Lab, Testing & Identity
Analytical methods, COA, identity testing and stability.
FCM Migration Testing
Readiness guide for food-contact migration testing — OML, SML, food simulants A/B/C/D1/D2/E, Annex V conditions, FDA Chapter 3 protocols and NIAS screening.
ISO/IEC 17025 Chemical Testing Labs
Plain-English readiness guide to ISO/IEC 17025:2017 for chemical testing laboratories — competence, impartiality, method validation, measurement uncertainty and ILAC-aligned accreditation.
Quality & Cross-Industry
ISO 9001, CAPA and cross-industry quality foundations.
AABB Blood Bank Standards
Readiness guide for blood banks and transfusion services against the AABB Standards for Blood Banks and Transfusion Services (33rd ed.) and 21 CFR 600/606/610.
ATEX & IECEx Explosive Atmosphere
Plain-English guide to ATEX 2014/34/EU, ATEX 1999/92/EC and IECEx — zones 0/1/2 and 20/21/22, equipment categories, EPDs and operator duties.
Blood, Tissue & Cell Therapy Readiness: The V5 Hub
Hub guide for blood banks, tissue establishments, cord blood banks and cell therapy manufacturers — 21 CFR 606/610/630, 21 CFR 1271, AABB, FACT/JACIE, EU Directive 2004/23/EC and the CAR-T pathway.
CMO / CDMO Quality Systems — Buyer's Guide for Contract Manufacturers
What pharma and biotech sponsors actually demand of a CMO/CDMO's quality system in 2026 — audit-readiness, sponsor visibility, multi-client data segregation, and software that scales beyond one client.
Codex MRL & Pesticide Residue
Readiness for Codex Maximum Residue Limits, EU Regulation 396/2005 and EPA tolerances (40 CFR 180) — residue trials, import tolerances and the active × crop × destination matrix.
Cord Blood Bank cGMP
Readiness guide for public and private cord blood banks — 21 CFR 1271 HCT/P, 21 CFR 610/630 BLA pathway for licensed cord blood, FACT-NetCord and AABB cord blood standards.
CPSIA Children's Product Certificate (CPC)
Plain-English guide to CPSIA — Children's Product Certificate, third-party testing at CPSC-accepted labs, tracking labels, lead and phthalate limits, and Section 15(b) reporting.
Cronobacter & Powdered Infant Formula
Operating manual for Cronobacter sakazakii control in powdered infant formula — FDA 2024 draft guidance, environmental monitoring, hygienic zoning and the post-Abbott Sturgis 2022 expectations.
Grade A PMO Readiness for Dairy Processors — IMS Listing Guide
What the Grade A Pasteurized Milk Ordinance (PMO) and the Interstate Milk Shippers (IMS) program expect from dairy processors — and how to keep your listing without paper chaos.
Document Control Process Explained
Plain-English guide to the document control process — what it is, the regulations behind it, the lifecycle, common audit findings, and how a modern eQMS makes it routine.
Donor Eligibility, Look-Back & Deviation
The cross-cutting spine for blood, tissue and cell therapy programmes — donor eligibility determination, post-donation look-back, deviation/SARE/BPDR reporting and the regulatory clocks.
DOT 49 CFR Hazmat Ground Shipping
Plain-English guide to US DOT hazmat under 49 CFR 171–180 with ADR / IMDG / IATA harmonisation — classification, packaging, marking, placarding, shipping papers and training.
EPA FIFRA Pesticide Manufacturing
Readiness guide for pesticide registrants and producers under FIFRA — Section 3 registration, establishment registration (Section 7), Section 6 reporting, label compliance and EPA inspections.
Extralabel Drug Use (AMDUCA) Veterinary
Readiness guide for veterinary extralabel drug use under the Animal Medicinal Drug Use Clarification Act (AMDUCA) and 21 CFR Part 530 — prescribing conditions, withdrawal interval determination, FARAD interface and residue avoidance evidence.
FACT-JACIE Accreditation Cell Therapy
Readiness guide for cellular therapy programmes pursuing or maintaining FACT-JACIE accreditation — clinical, collection and processing standards for HPC/cellular therapy and the CAR-T handoff.
FAO/WHO Pesticide Specifications
Readiness for FAO/WHO Joint Meeting on Pesticide Specifications (JMPS) — technical-grade vs formulated product specifications, impurity profiles, equivalence determination and the secondary-market path.
FDA 21 CFR 106 Infant Formula cGMP
Operating manual for 21 CFR 106 — infant formula cGMP, quality factors, audit requirements, and the 21 CFR 107 nutrient specs that drive the label and the recall.
FDA 21 CFR 1271 HCT/P
Readiness guide for human cells, tissues, and cellular and tissue-based products under 21 CFR Part 1271 — registration, donor eligibility, CGTP, adverse reaction reporting and 361 vs 351 boundary.
FDA 21 CFR 177 Food-Contact Polymers
Readiness guide for plastics and resin manufacturers supplying food-contact polymers under 21 CFR 177 — clearance routes, FCN, threshold of regulation, extractables and migration testing.
FDA 21 CFR 507 Animal Food PCQI
Operating manual for FSMA Preventive Controls for Animal Food — 21 CFR 507 cGMP, hazard analysis, PCQI plan and the disciplines FDA CVM inspects.
21 CFR 514 NADA/ANADA Submission
Readiness guide for FDA-CVM New Animal Drug Application (NADA) and Abbreviated NADA (ANADA) submissions under 21 CFR Part 514 — pre-submission, technical sections, supplements and post-approval.
21 CFR 606 Blood Establishment cGMP
Readiness guide for FDA-licensed blood establishments under 21 CFR 600/606/610/630 — cGMP for blood and blood components, BPDR reporting, licensure and inspection.
FDA Form 483 & Warning Letter Response Playbook
Operational playbook for FDA Form 483 observations and Warning Letter response — 15-business-day timeline, root-cause and CAPA discipline, executive escalation, commitments tracker and re-inspection readiness.
Foreign Material Control & Metal Detection
Practical guide to foreign material control for food manufacturers — metal detection and X-ray CCP validation and verification, magnets, sieves, glass and brittle plastic policy, reject and reconciliation discipline.
GHS / CLP / HazCom SDS & Classification
Plain-English guide to GHS, EU CLP and OSHA HazCom 2024 — 16-section SDS authoring, label elements, poison-centre PCN/UFI notification and revision discipline.
GLP 40 CFR Part 160
Plain-English guide to EPA Good Laboratory Practice (40 CFR Part 160) for pesticide studies — Study Director, QA Unit, raw data, archival and inspection readiness.
GFCO Gluten-Free Certification
Practical guide to GFCO certification — the 10 ppm gluten threshold, validation testing (R5 ELISA), segregation, supplier control, label rules under FDA 21 CFR 101.91 and EU 828/2014.
GMP Manufacturing
Plain-English readiness guide for GMP manufacturing — what cGMP requires today across drugs, devices, supplements and food, the operational spine inspectors look for, and a 90-day path from gap analysis to inspection-ready.
Health Canada Cannabis Regulations
Health Canada Cannabis Act and Cannabis Regulations readiness — licence classes, Good Production Practices (GPP), security clearances, plain packaging, promotion restrictions, CTLS monthly reporting and recall obligations.
IQ OQ PQ Process Validation
Plain-English guide to Installation, Operational, and Performance Qualification under FDA process validation guidance, EU GMP Annex 15, and ICH Q8/Q9/Q10. Stage-2 PPQ, statistical sampling, and continued process verification.
ISO 17034
Plain-English guide to ISO 17034:2016 — the international standard for the competence of reference material producers. CRM characterization, homogeneity, stability, metrological traceability, commutability, value assignment, uncertainty budgets and a path to accreditation.
ISO 9001:2015
Plain-English guide to ISO 9001:2015 — the international QMS standard. Risk-based thinking, process approach, leadership and the path to a clean certification audit.
ISPE GAMP RDI Records & Data Integrity
Plain-English guide to the ISPE GAMP Records & Data Integrity (RDI) Good Practice Guide — ALCOA+, data lifecycle, hybrid records, audit trail review, and a defensible RDI programme aligned with MHRA, FDA, WHO and PIC/S expectations.
Listeria Environmental Monitoring Program (EMP)
Build a credible Listeria EMP for ready-to-eat food — Zone 1–4 swabbing, vector investigation, FDA draft Listeria guidance, GFSI expectations, root-cause and trending discipline.
Low-Moisture Food Salmonella Control
Operating manual for Salmonella control in low-moisture foods — water activity targets, dry cleaning, hygienic zoning, environmental monitoring and the recall lessons from PCA, Jif and Daily Harvest.
MES vs ERP: The Honest Guide
MES vs ERP explained for pharma, food and medical-device plants — what each system actually does, where the boundary lives, and how to choose without ending up with two systems doing one job badly.
NDI Notification Readiness: 21 CFR 190.6 New Dietary Ingredient Dossier
FDA's New Dietary Ingredient (NDI) notification under 21 CFR 190.6 is a 75-day pre-market dossier with a ~75% historical rejection rate. This guide maps the safety, history-of-use and identity evidence FDA expects.
NIS2 & DORA
Plain-English guide to NIS2 (Directive (EU) 2022/2555) and DORA (Regulation (EU) 2022/2554) for life sciences IT — scope, essential vs important entities, ICT third-party risk, 24-hour incident reporting and how NIS2 stacks on Annex 11 and GxP.
OSHA PSM 29 CFR 1910.119 Process Safety Management
Plain-English guide to OSHA PSM — the 14 elements, PHA/HAZOP, MOC, mechanical integrity, EPA RMP overlap and EU Seveso III parallel.
OTC Monograph Drug Readiness — OMUFA & 21 CFR 330 Guide
What OTC monograph drug manufacturers actually need under the OTC Monograph Reform Act and OMUFA — facility registration, listing, GMP, and how to be FDA-ready.
Paperless Validation: The GAMP 5 + FDA CSA Playbook
Paperless validation, in practice: how to move CSV and qualification off paper into a Part 11 electronic execution system under GAMP 5 Second Edition and FDA CSA — without breaking your inspection record.
Pesticide Registration EPA & EU 1107/2009
Comparative readiness for active substance approval and product authorisation under FIFRA Section 3 and EU Regulation 1107/2009 — OECD data, zonal evaluation and the equivalence determination.
PFAS, BPA & Phthalate Restrictions in Plastics —
Readiness guide for emerging chemical restrictions on food-contact and consumer plastics — EU PFAS REACH proposal, California AB 1200, EU 2018/213 (BPA), Annex XVII phthalates.
Raw & Freeze-Dried Pet Food Pathogen Control
Operating manual for raw and freeze-dried pet food pathogen control — FDA CPG 690.800 zero-tolerance Salmonella, HPP validation, freeze-dry kill kinetics and finished-product testing.
REACH SVHC & RoHS Consumer Product
Plain-English guide to REACH SVHC and RoHS for consumer products — Annex XVII restrictions, candidate list communication (Article 33), SCIP database, RoHS 6+4 substances and supplier declarations.
Recall Management Plan: A Practical Guide
Plain-English guide to recall management — what a recall plan covers, the regulations, the four-hour decision drill, common failure modes, and how traceability software collapses the response window.
Recall Response Timeline & Coordination Playbook
Operational playbook for product recall coordination — 24-72-hour decision window, FDA/EMA/MHRA/Health Canada/TGA notification, classification (Class I/II/III), customer and consumer comms, effectiveness checks and FDA close-out.
Recycled Plastic Food-Contact Readiness — EU 2022/1616 & FDA
Readiness guide for recycled plastics in food contact — EU 2022/1616, EFSA opinions, FDA No Objection Letters, decontamination challenge tests, rPET and rHDPE.
Responsible Care RC14001
Plain-English readiness guide to the American Chemistry Council Responsible Care management system standard RC14001 — EHS&S integration with ISO 14001, Process Safety, Product Safety and Security Codes.
Salmonella Pet Food Environmental Monitoring
Operating manual for Salmonella control in pet food — zone-based EMP, post-Diamond 2012 and post-Mid America 2024 expectations, kill-step verification and CAPA.
Sanitary Equipment Design (3-A & EHEDG)
Hygienic equipment design for food and beverage manufacturers — 3-A Sanitary Standards, EHEDG guidelines, ISO 14159, cleanability, drainability, dead-leg elimination and the FDA / GFSI expectations.
Seafood HACCP Readiness — 21 CFR 123 Compliance Guide
What 21 CFR 123 Seafood HACCP actually requires of processors and importers — hazard analysis, CCPs, sanitation, records, and how to be FDA-ready without paper.
Supplier Portal: What It Is, How It Works, How to Pick One
Plain-English guide to supplier portals — what they do, why email-and-spreadsheet supplier management breaks, the must-have capabilities in 2026, and how to evaluate vendors.
TSCA Section 5 PMN & Chemical Inventory
Plain-English guide to US TSCA — Inventory status, Section 5 Pre-Manufacture Notice and SNUR, Section 8 CDR reporting and the PFAS Section 8(a)(7) reporting rule.
What Is CAPA? Corrective & Preventive Action Explained
Plain-English guide to CAPA — what it is, the regulatory basis, the eight-step process, common failure modes, and a defensible workflow you can run in a modern eQMS.
Missing the regulation you care about?
Tell us what you'd like covered and we'll prioritise it for the next batch.